invizyne.com (IZTC): מקדם החזר מותאם קצב צמיחה

The peg_co ratio demonstrates the dependence of Invizyne Technologies Inc. (IZTC) valuation on the efficiency of cell-free protein synthesis and the reduction of enzyme costs. 0.00 captures the magnitude of this parameter as SimpleSENCE implements cell-free molecule synthesis, although low production volumes and high reactor costs currently limit the company's operating leverage.

Invizyne Technologies Inc. (IZTC) is investing in fundamental science by recruiting biochemists to develop innovative enzymatic synthesis. This indicator compares the market value of shares with the net profit growth rate, allowing for the identification of an undervalued asset when the value is below one, as reflected in the valuation-to-earnings growth ratio.